Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Intra-aortic balloon pump device

Known as: IABP, Intra-Aortic Balloon Pump, intraaortic balloon pump 
A medical device that increases myocardial oxygen perfusion while at the same time increasing cardiac output. (ACC)
National Institutes of Health

Related topics

Related topics

4 relations
Collapsible balloon, deviceImplant of pulsation balloonIntra-Aortic Balloon Pumping

Broader (1)

Heart-Assist Devices

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Concomitant Intra-Aortic Balloon Pump Use in Cardiogenic Shock Requiring Veno-Arterial Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-Analysis
Background There are contrasting reports on the effectiveness of a concomitant intra-aortic balloon pump (IABP) in cardiogenic… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Review
2017
Review
2017
Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock
Despite a high rate of early revascularization and use of intra-aortic balloon pump counterpulsation therapy, the prognosis of… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
2017
Highly Cited
2017
Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction.
BACKGROUND Despite advances in treatment, mortality in acute myocardial infarction (AMI) complicated by cardiogenic shock (CS… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2013
Highly Cited
2013
Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial
BACKGROUND In current international guidelines the recommendation for intra-aortic balloon pump (IABP) use has been downgraded in… Expand
Is this relevant?
Highly Cited
2012
Highly Cited
2012
A Prospective, Randomized Clinical Trial of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump in Patients Undergoing High-Risk Percutaneous Coronary Intervention: The PROTECT II…
Background— Although coronary artery bypass grafting is generally preferred in symptomatic patients with severe, complex… Expand
  • figure 1
  • table 2
  • table 3
  • table 4
  • figure 2
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Intraaortic balloon support for myocardial infarction with cardiogenic shock.
BACKGROUND In current international guidelines, intraaortic balloon counterpulsation is considered to be a class I treatment for… Expand
  • table 1
  • table 2
  • table 2
  • table 3
  • figure 1
Is this relevant?
Review
2009
Review
2009
Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials.
AIMS Studies have compared safety and efficacy of percutaneous left ventricular assist devices (LVADs) with intra-aortic balloon… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2008
Highly Cited
2008
A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by…
OBJECTIVES The aim of this study was to test whether the left ventricular assist device (LVAD) Impella LP2.5 (Abiomed Europe GmbH… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock.
AIMS Mortality in cardiogenic shock (CS) following acute myocardial infarction (AMI) remains unacceptably high despite… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Renal Dysfunction after Myocardial Revascularization: Risk Factors, Adverse Outcomes, and Hospital Resource Utilization
Each year, 600 000 patients undergo myocardial revascularization with cardiopulmonary bypass and sustain profound physiologic… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE